Novel Approaches to the Control of Cyathostomins in Equids

Total Page:16

File Type:pdf, Size:1020Kb

Novel Approaches to the Control of Cyathostomins in Equids NOVEL APPROACHES TO THE CONTROL OF CYATHOSTOMINS IN EQUIDS THESIS SUBMITTED IN ACCORDANCE WITH THE REQUIREMENTS OF THE UNIVERSITY OF LIVERPOOL FOR THE DEGREE OF DOCTOR OF PHILOSOPHY BY LAURA ELIZABETH PEACHEY APRIL 2016 I ABSTRACT Novel approaches to the control of cyathostomins in equids Laura Elizabeth Peachey Cyathostomins, are clade 5 gastrointestinal (GI) nematodes infecting equids. They are associated with a range of pathologies, the most serious of which is larval cyathostominosis, a protein losing enteropathy with a 50 % mortality rate. Importantly, they are the most abundant GI nematode of equids in the developed world and, as they do not induce protective immunity, equids remain at risk of infection throughout their lives. The effective control of cyathostomins is currently threatened by the development of anthelmintic resistance (AR) to all three major classes of anthelmintic licenced for use in equids. Of primary concern is the emerging resistance to the macrocyclic lactones (MLs), which are the mainstay of cyathostomin control. It is therefore important that novel options for controlling cyathostomins are explored. In this study in vitro tests were used to explore a range of options for developing novel treatments against AR cyathostomins and improving the efficacy of the widely used ML, ivermectin (IVM). First the potential use of ethnoveterinary medicines for treatment of cyathostomins in equids in Ethiopia and the UK was explored (Chapters 3, 4 and 5). A participatory rural appraisal was performed in the Oromia region of Ethiopia to identify plants currently used as anthelmintics in equids and other livestock. A total of 37 species of plant were identified, data on dosing and side effects were also recorded. These data were triangulated with a literature review to identify five plants for in vitro screening for anthelmintic activity against cyathostomins. A literature review was used to identify plants for in vitro screening in the UK. A total of 138 publications, reporting the anthelmintic activity of plant extracts against nematodes, were found. The data collected was used to design a ranking system to provide a shortlist of five plant candidates. Shortlisted plants were collected, dried and chemically extracted to give crude extracts, which were screened against cyathostomins in the egg hatch test (EHT) and larval migration inhibition test (LMIT). A total of 7/9 plants screened in this way showed anthelmintic activity in either the EHT and/or the LMIT with median effective concentrations (EC-50s) in the range 0.18- 8.90 mg/ml. For some of the most efficacious extracts there were reports of in vivo efficacy against GI nematodes of other veterinary parasitic nematodes, making these good candidates for future in vivo trials. One of the plants shortlisted for the UK, for which there was extensive evidence of anthelmintic activity in the literature, was the cysteine proteinase (CP) containing Carica papaya. Extract from this species, papaya latex supernatant (PLS), could not be processed and tested using the same protocols as the other plant species, as the active compound is an enzyme. The EHT and LMIT were optimised for use with PLS and its efficacy evaluated in chapter 5. It was found that PLS had a potent anthelmintic effect against cyathostomins in the EHT, which was attributable to the action of CPs, with EC-50 values in repeats ranging between 0.12-0.22 µM. PLS also showed efficacy in the LMIT, although this appeared due to another active compound. To the authors knowledge this is the first report of efficacy of PLS against the free living stages of any parasitic nematode, which may indicate that cyathostomins are particularly susceptible to CPs. In chapter 6 the role of P-glycoproteins (P-gps) in IVM resistance in cyathostomins was investigated, with the more specific aim of assessing whether P-gp inhibitors could potentially be used in combination with IVM to improve its efficacy against AR parasites. The transcription of pgp-9, which is putatively associated with IVM resistance in Teladorsagia II circumcincta and Haemonchus contortus, was measured after exposure to IVM in in ML resistant (AR) versus anthelmintic naïve (AN) cyathostomin third stage larvae (L3). Pgp-9 expression was significantly increased after incubation with IVM in the AR, but not the AN, parasite population. Two in vitro tests, the LMIT and the larval development test (LDT), were used to assess the effect of a range of P-gp inhibitors (ketoconazole, pluronic 85 and ivermectin aglycone) on IVM efficacy in ML resistant (AR) versus anthelmintic naïve (AN) cyathostomins. In the LMIT ketoconazole and ivermectin aglycone conferred a significant increase in IVM efficacy in the AR parasites, but had less effect on the AN parasites. Pluronic 85 also had a profound effect on IVM efficacy which depended on IVM concentration, however there was no differential effect dependent on parasite population. In the LDT, ketoconazole and pluronic 85 both significantly increased IVM efficacy in both AR and AN parasites. These results suggest that there is a lifecycle stage-specific association of P-gps with AR cyathostomins, and that P-gp inhibitors could potentially be used to improve IVM efficacy in AR cyathostomin populations. In summary in this study has identified a range of potential novel treatments for cyathostomins. The data also suggest a role for P-gps in the emerging resistance to MLs, which could potentially be exploited to improve ML efficacy in AR cyathostomin populations. Importantly, this work will underpin the financial and ethical justification for future in vivo trials on the extracts/compounds tested here. III ACKNOWLEDGEMENTS I would like to thank my primary supervisor Dr Jane Hodgkinson for her endless support and encouragement, her belief in my ability and her persistence in obtaining further funding so that I could complete my PhD. In addition her support through some difficult personal circumstances was invaluable and I will appreciate this for many years to come. I would also like to thank my supervisor Dr Gina Pinchbeck, firstly for inspiring me to do this project, and secondly for her continued support and willingness to help in any way possible. I am also indebted to my supervisor Professor Jacqui Matthews, for providing me with the in vitro tools to perform this project, and for her thorough critique of my thesis and publications. I have learnt a huge amount from her rigorous approach, and I hope to take these skills forward with me in my research career. There are many other staff and students at the University of Liverpool and collaborating institutions without whom this project would not have been possible, and whom I would like to thank; Dr. Claire Scantlebury at the University of Liverpool who performed the participatory rural appraisal in Ethiopia; Mairi Mitchell, Valerie Relf, and Claire McArthur at Moredun Research Institute for their guidance with in vitro tests; Professor Sebsebe Demissew at the University of Addis Ababa for his assistance with plant identification; Dr Faith Burden, Dr Getachew Mulugeta, Nikki Stradling and Liz Hazell-Smith at the Donkey Sanctuary for their support throughout the project and assistance with plant and parasite sample collection; Gebre Tefera from SPANA, Ethiopia for his assistance with plant collection; Dr Etana Debela at the University of Hawassa, Ethiopia, for his assistance with plant extractions; Timothy Baxter at Ness Gardens, University of Liverpool for his help with sourcing UK plants; Ann Leyden at the University of Liverpool Chemistry Department for allowing me to perform plant extractions in her laboratory; Dr Buttle at the University of Sheffield for his assistance with the cysteine proteinase enzyme titrations; Dr Jerzy Behnke and Fadlul Mansur at the University of Nottingham for donating papaya latex supernatant and providing advice; Dr Anne Lespine at Institut national de la recherche agronomique, Toulouse, for donating ivermectin aglycone and providing advice; Professor Georg von Samson-Himmelstjerna and Dr Jurgen Krucken at the Free University of Berlin for providing sequence data; Dr Ben Makepeace at the University of Liverpool for his advice regarding real time PCR; Catherine Hartley and Jenna Dawson at the University of Liverpool for their support in the laboratory and help with larval cultures; and last but not least the Veterinary Parasitology research group for their fabulous, moral boosting support. Finally, and in many ways most importantly, special thanks must go to some of my family. I would like to take this opportunity to dedicate this thesis to my late father, Tony Peachey, who sadly passed away during my PhD. He has been my inspiration throughout my scientific career, and has instilled in me a deep love of science and truth, which will remain with me forever. This PhD is his achievement, as much as it is mine. I would also like to dedicate this thesis to my darling daughter, Ada, who came into this world shortly after my Father left it. Much of the time that went into this PhD was rightfully hers. She has put up with an absent Mummy IV brilliantly, and therefore deserves much of the credit. She is a beautiful inspiration in everything I do. Next I would like to thank my Mother enormously for her strength, support with childcare, thesis proof reading and for believing in me against all odds. Huge thanks must also go to my parents in law Jon and Julie Fairhurst, whose help with childcare in the vital last stages of thesis writing has been absolutely
Recommended publications
  • Enzymes Handling/Processing
    Enzymes Handling/Processing 1 Identification of Petitioned Substance 2 3 This Technical Report addresses enzymes used in used in food processing (handling), which are 4 traditionally derived from various biological sources that include microorganisms (i.e., fungi and 5 bacteria), plants, and animals. Approximately 19 enzyme types are used in organic food processing, from 6 at least 72 different sources (e.g., strains of bacteria) (ETA, 2004). In this Technical Report, information is 7 provided about animal, microbial, and plant-derived enzymes generally, and more detailed information 8 is presented for at least one model enzyme in each group. 9 10 Enzymes Derived from Animal Sources: 11 Commonly used animal-derived enzymes include animal lipase, bovine liver catalase, egg white 12 lysozyme, pancreatin, pepsin, rennet, and trypsin. The model enzyme is rennet. Additional details are 13 also provided for egg white lysozyme. 14 15 Chemical Name: Trade Name: 16 Rennet (animal-derived) Rennet 17 18 Other Names: CAS Number: 19 Bovine rennet 9001-98-3 20 Rennin 25 21 Chymosin 26 Other Codes: 22 Prorennin 27 Enzyme Commission number: 3.4.23.4 23 Rennase 28 24 29 30 31 Chemical Name: CAS Number: 32 Peptidoglycan N-acetylmuramoylhydrolase 9001-63-2 33 34 Other Name: Other Codes: 35 Muramidase Enzyme Commission number: 3.2.1.17 36 37 Trade Name: 38 Egg white lysozyme 39 40 Enzymes Derived from Plant Sources: 41 Commonly used plant-derived enzymes include bromelain, papain, chinitase, plant-derived phytases, and 42 ficin. The model enzyme is bromelain.
    [Show full text]
  • Biochemistry and the Genomic Revolution 1.1
    Dedication About the authors Preface Tools and Techniques Clinical Applications Molecular Evolution Supplements Supporting Biochemistry, Fifth Edition Acknowledgments I. The Molecular Design of Life 1. Prelude: Biochemistry and the Genomic Revolution 1.1. DNA Illustrates the Relation between Form and Function 1.2. Biochemical Unity Underlies Biological Diversity 1.3. Chemical Bonds in Biochemistry 1.4. Biochemistry and Human Biology Appendix: Depicting Molecular Structures 2. Biochemical Evolution 2.1. Key Organic Molecules Are Used by Living Systems 2.2. Evolution Requires Reproduction, Variation, and Selective Pressure 2.3. Energy Transformations Are Necessary to Sustain Living Systems 2.4. Cells Can Respond to Changes in Their Environments Summary Problems Selected Readings 3. Protein Structure and Function 3.1. Proteins Are Built from a Repertoire of 20 Amino Acids 3.2. Primary Structure: Amino Acids Are Linked by Peptide Bonds to Form Polypeptide Chains 3.3. Secondary Structure: Polypeptide Chains Can Fold Into Regular Structures Such as the Alpha Helix, the Beta Sheet, and Turns and Loops 3.4. Tertiary Structure: Water-Soluble Proteins Fold Into Compact Structures with Nonpolar Cores 3.5. Quaternary Structure: Polypeptide Chains Can Assemble Into Multisubunit Structures 3.6. The Amino Acid Sequence of a Protein Determines Its Three-Dimensional Structure Summary Appendix: Acid-Base Concepts Problems Selected Readings 4. Exploring Proteins 4.1. The Purification of Proteins Is an Essential First Step in Understanding Their Function 4.2. Amino Acid Sequences Can Be Determined by Automated Edman Degradation 4.3. Immunology Provides Important Techniques with Which to Investigate Proteins 4.4. Peptides Can Be Synthesized by Automated Solid-Phase Methods 4.5.
    [Show full text]
  • “Joy” Winuthayanon, Bs.N., Ph.D
    WIPAWEE “JOY” WINUTHAYANON, BS.N., PH.D. School of Molecular Biosciences Center for Reproductive Biology College of Veterinary Medicine Washington State University Biotechnology Life Science Building, Pullman, WA 99164 509.335.8296 | [email protected] | https://labs.wsu.edu/winuthayanon EDUCATION 2003-2009 Ph.D. Human Physiology Mahidol University, Bangkok, Thailand Doctoral Program in the Department of Physiology, Faculty of Science Evaluation and characterization for the estrogenic activity of diarylheptanoids from Curcuma comosa PI: Pawinee Piyachaturawat, Ph.D. 1998-2002 B.Sc. Nursing Science (Second Class Honors) Mahidol University, Bangkok, Thailand School of Nursing, Faculty of Medicine Ramathibodi Hospital Specialty: Nursing and Midwifery POSITIONS effective 07/2021 Associate Professor (Tenured) School of Molecular Biosciences, College of Veterinary Medicine, Washington State University (WSU), Pullman, WA Training Faculty, MARC-WSU Program (05/2021–present) Graduate Faculty, adjunct (05/2020–present) Clinical & Translational Sciences, Dept. of Veterinary Clinical Sciences, WSU Faculty Research Mentor (06/2018–present) Pacific Northwest Louis Stokes Alliance for Minority Participation (LSAMP), WSU Faculty Research Mentor (01/2016–present) Team Mentoring Program (TMP), WSU 08/2015–06/2021 Assistant Professor School of Molecular Biosciences, College of Veterinary Medicine, WSU 08/2009–07/2015 Post-doctoral Fellow National Institutes of Health/National Institute of Environmental Health Sciences (NIH/NIEHS), Research Triangle Park (RTP), NC Reproductive & Developmental Biology Laboratory PIs: Kenneth Korach, Ph.D. and Carmen Williams, M.D. Ph.D. 03/2007–06/2008 Pre-doctoral Fellow NIH/NIEHS, Research Triangle Park, NC Laboratory of Reproduction and Developmental Toxicology PI: Kenneth Korach, Ph.D. 06/2003–01/2009 Graduate Research Assistant Department of Physiology, Faculty of Sciences, Bangkok, Thailand PI: Pawinee Piyachaturawat, Ph.D.
    [Show full text]
  • Distribution of Phytoestrogenic Diarylheptanoids and Sesquiterpenoids Components in Curcuma Comosa Rhizomes and Its Related Spec
    Revista Brasileira de Farmacognosia 27 (2017) 290–296 ww w.elsevier.com/locate/bjp Original Article Distribution of phytoestrogenic diarylheptanoids and sesquiterpenoids components in Curcuma comosa rhizomes and its related species a,b,∗ c,∗ Vichien Keeratinijakal , Sumet Kongkiatpaiboon a Department of Agronomy, Faculty of Agriculture, Kasetsart University, Bangkok, Thailand b National Center for Agricultural Biotechnology, Kasetsart University, Bangkok, Thailand c Drug Discovery and Development Center, Thammasat University (Rangsit Campus), Pathumthani, Thailand a b s t r a c t a r t i c l e i n f o Article history: Curcuma comosa Roxb., Zingiberaceae, a phytoestrogen-producing herb with vernacularly named “Wan Received 30 August 2016 Chak Mod Loog” in Thailand, has been traditionally used for treatment of gynecologic diseases and sold Accepted 16 December 2016 as food supplement in the market. However, similar rhizomes of its related species may lead to the Available online 21 March 2017 confusion in the uses of this plant. This study was aimed to investigate the phytochemical constituents of different Curcuma spp. that used as “Wan Chak Mod Loog”. Characteristic major compounds were isolated Keywords: and identified. Phytochemical analysis of 45 Curcuma samples representing Curcuma sp., C. latifolia, and C. Wan Chak Mod Loog comosa were analyzed and compared with their phylogenetic relationship inferred by Amplified Fragment Phytochemicals Length Polymorphism analysis. Phytoestrogen diarylheptanoids were found in all samples of C. comosa Phytoestrogen-producing herb Diarylheptanoids while sesquiterpenoids including hepatoxic zederone were found in C. latifolia and Curcuma sp. samples. Sesquiterpenoids © 2017 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
    [Show full text]
  • Molecular Insights Into Bromelain Application in Industry and Health Care
    Biosc.Biotech.Res.Comm. Special Issue Vol 13 No 15 (2020) Pp-36-46 Molecular Insights into Bromelain Application in Industry and Health Care Sushma S. Murthy and T. Bala Narsaiah 1Research Scholar, Department of Chemical Engineering, JNTUA College of Engineering, Ananthapuram-515002, Andhra Pradesh, India 2Department of Chemical Engineering, JNTUA College of Engineering, Ananthapuram-515002, Andhra Pradesh, India ABSTRACT Bromelain is a cysteine protease derived from the stem and fruit of the pineapple. It has a significant role in pharmacological and clinical applications. Studies have shown Bromelain to be a potent photoactive compound that has a wide application in industry. It has also been shown to be effective in treatment of cancer, inflammation, and allergies. It has a distinct immunomodulatory activity which forms an important strategy in its utilization as a therapeutic agent. Bromelain plays a significant role at molecular level by regulating the expression of proteins that are potential therapeutic targets. Bromelain is used extensively worldwide as an herbal medicine as it promises good efficacy and has no side effects. This paper reviews the general characteristics of Bromelain, its separation process, and its use in industries and healthcare as a therapeutic agent. The present review identifies that there is lack of knowledge pertaining to the mode of action of Bromelain in inhibiting transcriptional factors and in controlling cancer. An in-detail analysis in this area might help in expanding the therapeutic scope of Bromelain. KEY WORDS: BROMELAIN, CANCER, PHARMacOLOGICAL actiVITY, SEpaRatiON, TRANSCRIPTION FactORS. INTRODUCTION because of its wide benefits to the human system. The stem part of the plant, which is inexpensive and is usually The Bromelain protease is isolated from the stem and discarded, has a high concentration of bromelain and fruit of Pineapple (Ananas comosus,).
    [Show full text]
  • Genus Curcuma
    JOURNAL OF CRITICAL REVIEWS ISSN- 2394-5125 VOL 7, ISSUE 16, 2020 A REVIEW ON GOLDEN SPECIES OF ZINGIBERACEAE FAMILY: GENUS CURCUMA Abdul Mubasher Furmuly1, Najiba Azemi 2 1Department of Analytical Chemistry, Faculty of Chemistry, Kabul University, Jamal Mina, 1001 Kabul, Kabul, Afghanistan 2Department of Chemistry, Faculty of Education, Balkh University, 1701 Balkh, Mazar-i-Sharif, Afghanistan Corresponding author: [email protected] First Author: [email protected] Received: 18 March 2020 Revised and Accepted: 20 June 2020 ABSTRACT: The genus Curcuma pertains to the Zingiberaceae family and consists of 70-80 species of perennial rhizomatous herbs. This genus originates in the Indo-Malayan region and it is broadly spread all over the world across tropical and subtropical areas. This study aims to provide more information about morphological features, biological activities, and phytochemicals of genus Curcuma for further advanced research. Because of its use in the medicinal and food industries, Curcuma is an extremely important economic genus. Curcuma species rhizomes are the source of a yellow dye and have traditionally been utilized as spices and food preservers, as a garnishing agent, and also utilized for the handling of various illnesses because of the chemical substances found in them. Furthermore, Because of the discovery of new bioactive substances with a broad range of bioactivities, including antioxidants, antivirals, antimicrobials and anti-inflammatory activities, interest in their medicinal properties has increased. Lack of information concerning morphological, phytochemicals, and biological activities is the biggest problem that the researcher encountered. This review recommended that collecting information concerning the Curcuma genus may be providing more opportunities for further advanced studies lead to avoid wasting time and use this information for further research on bioactive compounds which are beneficial in medicinal purposes KEYWORDS: genus Curcuma; morphology; phytochemicals; pharmacological 1.
    [Show full text]
  • Role of Systemic Enzymes in Infections
    Article ID: WMC002495 2046-1690 Role of Systemic Enzymes in Infections Corresponding Author: Dr. Sukhbir Shahid, Consultant Pediatrician, Pediatrics - India Submitting Author: Dr. Sukhbir Shahid, Consultant Pediatrician, Pediatrics - India Article ID: WMC002495 Article Type: Review articles Submitted on:22-Nov-2011, 08:16:56 AM GMT Published on: 22-Nov-2011, 02:34:00 PM GMT Article URL: http://www.webmedcentral.com/article_view/2495 Subject Categories:COMPLEMENTARY MEDICINE Keywords:Enzymes, Systemic enzymes, Infections, Sepsis, Proteolytic, Supplementary How to cite the article:Shahid S . Role of Systemic Enzymes in Infections . WebmedCentral COMPLEMENTARY MEDICINE 2011;2(11):WMC002495 Source(s) of Funding: None Competing Interests: None WebmedCentral > Review articles Page 1 of 13 WMC002495 Downloaded from http://www.webmedcentral.com on 23-Dec-2011, 07:57:46 AM Role of Systemic Enzymes in Infections Author(s): Shahid S Abstract infections[4]. The ‘battle’ between the host’s immunity and organism leads to a lot of ‘molecular’morbidity and mortality. Anti-infective agents do help but at times benefit is marginal. These agents may sometimes Enzymes are complex macromolecules of amino-acids worsen the situation through release of immune which bio-catalyse various body processes. Adequate complexes and dead bacilli into the blood stream. concentrations of enzymes are essential for optimal They also fail to reverse the hemodynamic instability functioning of the immune system. During infections, and immune paralysis characteristic of these body’s enzymatic system is attacked and hence the infections[4]. Supplementation with drugs targeted immune system is also likely to derange. This may be against this ‘choatic’ or ‘dysfunctional’ immune detrimental for the host’s well-being and existence.
    [Show full text]
  • Concentrate of Proteolytic Enzymes Enriched in Bromelain
    20 September 2012 EMA/648483/2012 Committee for Medicinal Products for Human Use (CHMP) Assessment report NexoBrid Concentrate of proteolytic enzymes enriched in bromelain Procedure No. EMEA/H/C/002246 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. 7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8416 E-mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged. Table of contents 1. Background information on the procedure .............................................. 5 1.1. Submission of the dossier.................................................................................... 5 1.2. Steps taken for the assessment of the product ....................................................... 6 2. Scientific discussion ................................................................................ 7 2.1. Introduction ...................................................................................................... 7 2.2. Quality aspects .................................................................................................. 9 2.3. Non-clinical aspects .......................................................................................... 20 2.4. Clinical aspects ................................................................................................ 29 2.5.
    [Show full text]
  • Isolation and Characterization of Phytoconstituents from Myanmar Medicinal Plants
    Isolation and Characterization of Phytoconstituents from Myanmar Medicinal Plants Dissertation zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) vorgelegt der Mathematisch-Naturwissenschaftlich-Technischen Fakultät (mathematisch-naturwissenschaftlicher Bereich) der Martin-Luther-Universität Halle-Wittenberg von M. Sc. Myint Myint Khine geboren am 24. September 1964 in Yangon (Myanmar) Gutachter: 1. Prof. Dr. Ludger Wessjohann 2. Prof. Dr. Karsten Krohn Halle (Saale), den 03.03.2006 DECLARATION I hereby declare that I have carried out the analyses and written the thesis myself and that I did not use any devices or received relevant help from any persons other than those mentioned in the text. This dissertation has not been submitted before. …31.01.06…… …………….. Date… Signature Acknowledgements The present study was carried out at the Leibniz Institute for Plant Biochemistry [Halle (Saale)]. Financial support was provided by the Gottlieb Daimler- und Karl Benz-Stiftung. This study would not have succeeded without the permission of the Ministry for Education from Myanmar. In addition, I wish to express my appreciation and gratitude to the many people who have in one way or another helped me over the course of study. In particular I would like to thank the following: Prof. Ludger Wessjohann, my main supervisor, for inviting me to do my Ph. D. work at IPB and for the encouragements, allowing me to develop at my own pace. Dr. Norbert Arnold and Dr. Katrin Franke, my supervisors, for the advice and encouragement as well as supporting my ideas. Dr. A. Porzel for the discussions and NMR-spectra measurement. Mrs. M. Süsse for the NMR-, IR- and UV- spectra measurement.
    [Show full text]
  • Biologically Active Proteins from Curcuma Comosa Roxb. Rhizomes
    Journal of Medicinal Plants Research Vol. 5(21), pp. 5208-5215, 9 October, 2011 Available online at http://www.academicjournals.org/JMPR ISSN 1996-0875 ©2011 Academic Journals Full Length Research Paper Biologically active proteins from Curcuma comosa Roxb. rhizomes Apaporn Boonmee 1, Chantragan Srisomsap 2, Aphichart Karnchanatat 3 and Polkit Sangvanich 1* 1Research Center for Bioorganic Chemistry, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand. 2Laboratory of Biochemistry, Chulabhorn Research Institute, Bangkok, 10210, Thailand. 3The Institute of Biotechnology and Genetic Engineering, Chulalongkorn University, Bangkok, 10330, Thailand. Accepted 22 December, 2010 Curcuma comosa Roxb., belongs to Zingiberaceae family, is used in folk medicine to relieve postpartum uterine inflammation. The crude protein from C. comosa was assayed to find some interesting bioactivities. The hemagglutination activity assay was performed with erythrocytes from seven different species, and revealed a strong specificity towards rabbit erythrocytes only. After isolation by Concanavalin A (Con A) affinity column chromatography and likely identification by tryptic peptide tandem mass spectrometry, two separate proteins with homology to other plant lectins were found. The free radical scavenging capacity and the superoxide dismutase (SOD) enzyme activity were used to determine any potential antioxidant activity. The results suggested that there were three different SODs in the crude rhizome protein extract. These enzymes were stable over a wide range of temperatures (up to 80°C) which may make them useful for further applications. In addition, alpha- glucosidase inhibitory activity also was found in this plant. Key words: Hemagglutination, antioxidant, superoxide dismutase, alpha-glucosidase inhibition, Curcuma comosa. INTRODUCTION Plants in the Zingiberaceae are widely distributed in many of the biologically active proteins from Southeast Asia, especially in Thailand.
    [Show full text]
  • Food and Drugs
    21 Parts 300 to 499 Revised as of April 1, 2004 Food and Drugs Containing a codification of documents of general applicability and future effect As of April 1, 2004 With Ancillaries Published by Office of the Federal Register National Archives and Records Administration A Special Edition of the Federal Register VerDate mar<24>2004 15:46 Apr 22, 2004 Jkt 203068 PO 00000 Frm 00001 Fmt 8091 Sfmt 8091 Y:\SGML\203068F.XXX 203068F U.S. GOVERNMENT PRINTING OFFICE WASHINGTON : 2004 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512-1800; DC area (202) 512-1800 Fax: (202) 512-2250 Mail: Stop SSOP, Washington, DC 20402–0001 VerDate mar<24>2004 15:46 Apr 22, 2004 Jkt 203068 PO 00000 Frm 00002 Fmt 8092 Sfmt 8092 Y:\SGML\203068F.XXX 203068F Table of Contents Page Explanation ................................................................................................ v Title 21: Chapter I—Food and Drug Administration, Department of Health and Human Services (Continued) ................................................. 3 Finding Aids: Material Approved for Incorporation by Reference ............................ 335 Table of CFR Titles and Chapters ....................................................... 337 Alphabetical List of Agencies Appearing in the CFR ......................... 355 List of CFR Sections Affected ............................................................. 365 iii VerDate May<04>2004 11:24 May 20, 2004 Jkt 203068 PO 00000 Frm 00003 Fmt 8092 Sfmt 8092 Y:\SGML\203068F.XXX 203068F Cite this Code: CFR To cite the regulations in this volume use title, part and section num- ber. Thus, 21 CFR 300.50 refers to title 21, part 300, section 50. iv VerDate mar<24>2004 15:46 Apr 22, 2004 Jkt 203068 PO 00000 Frm 00004 Fmt 8092 Sfmt 8092 Y:\SGML\203068F.XXX 203068F Explanation The Code of Federal Regulations is a codification of the general and permanent rules published in the Federal Register by the Executive departments and agen- cies of the Federal Government.
    [Show full text]
  • Chapter 11 Cysteine Proteases
    CHAPTER 11 CYSTEINE PROTEASES ZBIGNIEW GRZONKA, FRANCISZEK KASPRZYKOWSKI AND WIESŁAW WICZK∗ Faculty of Chemistry, University of Gdansk,´ Poland ∗[email protected] 1. INTRODUCTION Cysteine proteases (CPs) are present in all living organisms. More than twenty families of cysteine proteases have been described (Barrett, 1994) many of which (e.g. papain, bromelain, ficain , animal cathepsins) are of industrial impor- tance. Recently, cysteine proteases, in particular lysosomal cathepsins, have attracted the interest of the pharmaceutical industry (Leung-Toung et al., 2002). Cathepsins are promising drug targets for many diseases such as osteoporosis, rheumatoid arthritis, arteriosclerosis, cancer, and inflammatory and autoimmune diseases. Caspases, another group of CPs, are important elements of the apoptotic machinery that regulates programmed cell death (Denault and Salvesen, 2002). Comprehensive information on CPs can be found in many excellent books and reviews (Barrett et al., 1998; Bordusa, 2002; Drauz and Waldmann, 2002; Lecaille et al., 2002; McGrath, 1999; Otto and Schirmeister, 1997). 2. STRUCTURE AND FUNCTION 2.1. Classification and Evolution Cysteine proteases (EC.3.4.22) are proteins of molecular mass about 21-30 kDa. They catalyse the hydrolysis of peptide, amide, ester, thiol ester and thiono ester bonds. The CP family can be subdivided into exopeptidases (e.g. cathepsin X, carboxypeptidase B) and endopeptidases (papain, bromelain, ficain, cathepsins). Exopeptidases cleave the peptide bond proximal to the amino or carboxy termini of the substrate, whereas endopeptidases cleave peptide bonds distant from the N- or C-termini. Cysteine proteases are divided into five clans: CA (papain-like enzymes), 181 J. Polaina and A.P. MacCabe (eds.), Industrial Enzymes, 181–195.
    [Show full text]